Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press conference held in San Francisco, California, on Jan. 15. [LEE JAE-LIM ...

Hanmi Science, the holding company of Hanmi Pharmaceutical, announced on Dec. 26 that Lim will sell a 5% stake—equivalent to 3.42 million shares—to Shin Dong-kuk, chairman of Hanyang Precision ...

LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report fourth quarter 2024 ...

Ben Brodkowitz; Investor Relations; Financial Profiles, Inc. Bonita Lee; President, Chief Executive Officer, Director; Hanmi Financial Corp Anthony Kim; Senior Executive Vice President ...

Please go ahead. Thank you, Matt, and thank you all for joining us today to discuss Hanmi's fourth quarter and full year 2024 results. This afternoon, Hanmi issued its earnings release and ...

SAN FRANCISCO ― Hanmi Pharmaceutical is poised to bring a new chapter to obesity treatment, a topic that has garnered significant attention at this year’s JP Morgan Healthcare Conference.

LOS ANGELES, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today reported financial results for ...

Ben Brodkowitz; Investor Relations; Financial Profiles, Inc. Bonita Lee; President, Chief Executive Officer, Director; Hanmi Financial Corp Anthony Kim; Senior Executive Vice President, Chief Banking ...

Operator: Ladies and gentlemen, welcome to Hanmi Financial Corporation’s Fourth Quarter and Full Year 2024 Conference Call. As a reminder, today’s call is being recorded for replay purposes.

Choi In-young, head of the Hanmi Pharmaceutical R&D Center, noted during a briefing at the JP Morgan Healthcare Conference (JPM) held in San Francisco on the 15th (local time) that "the biggest ...